Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Baseline FSH Predicts Semen Parameter Response in Infertile Men on Clomiphene Citrate
1urologist at the Center for Reproductive Medicine, Scott Department of Urology, Baylor College of Medicine
2,urologists with the Department of Urology at the University of Virginia
3urologist with Male Reproductive Surgery, Urology Indiana
4urologist with the Division of Urologic Surgery, University of North Carolina at Chapel Hill
Background: Clomiphene citrate (CC) is a selective estrogen receptor modulator that increases gonadotropin production and may improve spermatogenesis. The purpose of the study was to examine the effects of CC on hormone levels and spermatogenesis in men treated for infertility, and to determine whether it is possible to predict positive treatment outcomes, in terms of hormonal or spermatogenic response to CC prior to treatment.
Methods: The cases of 90 men, who were prescribed CC for infertility, were retrospectively reviewed. Serum values for follicle stimulating hormone (FSH), luteinizing hormone (LH), total testosterone (TT), free testosterone (FT), sex hormone binding globulin (SHBG), estradiol (E) as well as complete semen analyses were collected before and after CC. Exclusion criteria included azoospermia and men treated with testosterone, human chorionic gonadotropin, or recombinant FSH during the previous 6 months.
Results: Forty-two men (46.7%) with a mean age of 35±6years met the inclusion criteria for analysis. Serum hormone values significantly (p<0.01) increased for FSH (3.4 mIU/mL), LH (2.7 mIU/mL), TT (250.0 ng/dL), FT (5.2 ng/dL), SHBG (5.2nmoI/L) and E ( 1.9 ng/dL). Patients with a baseline FSH of 2 mIU/mL had no change in sperm density( -13.1±32.0 million/mL) or total motile count (-20.6 ± 45.5 million). Men with an initial FSH>2 (n=32) had a mean change in density of +1.68±7.46 million/mL and demonstrateda significant improvement in total motile sperm (+3.4±13.96 million). There were no significant differences between the serum hormone levels in men with baseline FSH levels of 2 or >2 mIU/mL.Conclusions: Infertile men exhibit significant increases in serum hormone levels with CC. Those with FSH >2 mIU/mL had improved sperm density and motility relative to men with FSH 2mIU/mL. FSH prior to initiating CC therapy may be a useful predictor of improvement in semen parameters.
Infertility, Male; Clomiphene Citrate; Idiopathic Infertility; Hypogonadism, Male
Ryan Smith,Ella J. Doerge,Larry Lipshultz,Jason R. Kovac,Robert Coward. Baseline FSH Predicts Semen Parameter Response in Infertile Men on Clomiphene Citrate. Journal of Men's Health. 2015. 11(5);22-29.
1. Louis, J.F., Thoma, M. E., Sorensen, D. N. et al: The prevalence of couple infertility in the United States from a male perspective: evidence from a nationally representative sample. Andrology, 1: 741, 2013.
2. Thonneau, P.,Marchand, S., Tallec, A. et al: Incidence and main causes of infertility in a resident population (1,850,000) of three French regions (1988-1989). Hum Reprod, 6: 811, 1991
3. Ferlin, A., Raicu, F., Gatta, V. et al: Male infertility: role of genetic background. Reprod Biomed Online, 14: 734, 2007
4. Kovac, J.R., Pastuszak, A.W., Lamb, D. J.: The use of genomics, proteomics, and metobolomics in identifying biomarkers of male infertility. Fertil Steril, 99: 998, 2013
5. Ko, E. Y., Siddiqi, K., Brannigan, R. E. et al: Empirical medical therapy for idiopathic male infertility: a survey of the American Urological Association. J Urol, 187:973, 2012
6. Liu, P. Y. Handelsman, D. J.: The present and future state of hormonal treatment for male infertility. Hum Reprod Update, 9: 9, 2003
7. Foss, G. L., Tindall, V. R., Birkett, J. P.: The treatment of subfertile men with clomiphene citrate. J Reprod Fertil, 32: 167, 1973
8. Ghanem, H., Shaeer, O., El-Segini, A.: Combination clomiphene citrate and antioxidant therapy for idiopathic male infertility: a randomized controlled trial. Fertil Steril, 93: 2232, 2010
9. Matsumiya, K., Kitamura, M., Kishikawa, H. et al: A prospective comparative trial of a gonadotropin-releasing hormone analogue with clomiphene citrate for the treatment of oligoasthenozoospermia. Int. J Urol, 5: 361, 1998
10. Mellinger, R.C., Thompson, R.J.: The effect of clomiphene citrate in male fertility. Fertil Steril, 17:94, 1966
11. Ronnberg, L.: The effect of clomiphene citrate on different sperm parameters and serum hormone levels in preselected infertile men: a controlled double-blind cross-over study. Int J Androl, 3: 479, 1980
12. Willets, A.E., Corbo, J.M., Brown, J. N: Clomiphene for treatment of idiopathic male infertility. Reprod Sci, 20: 739, 2013
13. A double-blind trial of clomiphene citrate for the treatment of idiopathic male infertility. World Health Organization. Int J. Androl, 15: 299, 1992
14. Vandekerckhove, P., Lilford, R., Vail., A. et al: Clomiphene or tamoxifen for idiopathic oligo/asthenospermia. Cochrane Database Syst Rev: CD000151, 2000
15. Katz, D.J., Nabulsi, O., Tal, R. et al: Outcomes of clominphene citrate treatment in young hypogonadal men. BJU Int, 110: 573, 2012
16. Moskovic, D.J., Katz, D.J., Akhavan, A. et al: Clomiphene citrate is safe and effective for long-term management of hypogonadism. BJU Int, 110: 1524, 2012
17. Bardin, C. W., Ross, G.T., Lipsett, M. B.: Site of action of clomiphene citrate in men: a study of the pituitary-Leydig cell axis. J Clin Endocrinol Metab, 27: 1558, 1967
18. Vandekerckhove, P., Lilford, R., Vail, A et al: WITHDRAWN: Clomiphene or tamoxifen for idiopathic olig/asthenospermia. Cochrane Database Sys Rev: CD000151, 1996
19. Willets, A.E., Corbo, J.M., J.N.: Clomiphene for the treatment of male infertility. Reprod Sci, 2012
20. Boyle, K.: Nonsurgical treatment of male infertility: empiric therapy. In: Infertility in the Male, Fourth ed. Edited by L. Lipshultz, Howards, S., Neiderberger, C.: Cambridge, UK: Cambridge University Press pp. 438-453, 2009
21. Chua, M.E., Escusa, K. G., Luna, S. et al: Revisiting oestrogen antagonists (clomiphene or tamoxifen) as medical empiric therapy for idiopathic male infertility: a met-analysis. Andrology, 1: 749, 2013
22. Hendriks, D. J., Mol, B.W., Bancsi, L. F. et al: The clomiphene citrate challenge test for the prediction of poor ovarian response and nonpregnancy in patients undergoing in vitro fertilization: a systematic review. Fertil Steril, 86: 807, 2006
Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.
Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.
Directory of Open Access Journals (DOAJ) DOAJ is a unique and extensive index of diverse open access journals from around the world, driven by a growing community, committed to ensuring quality content is freely available online for everyone.
SCImago The SCImago Journal & Country Rank is a publicly available portal that includes the journals and country scientific indicators developed from the information contained in the Scopus® database (Elsevier B.V.)
Publication Forum - JUFO (Federation of Finnish Learned Societies) Publication Forum is a classification of publication channels created by the Finnish scientific community to support the quality assessment of academic research.
Scopus: CiteScore 0.9 (2023) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.
Norwegian Register for Scientific Journals, Series and Publishers Search for publication channels (journals, series and publishers) in the Norwegian Register for Scientific Journals, Series and Publishers to see if they are considered as scientific. (https://kanalregister.hkdir.no/publiseringskanaler/Forside).
Top